nodes	percent_of_prediction	percent_of_DWPC	metapath
Flucytosine—Crystalluria—Fludarabine—lymphatic system cancer	0.0488	0.0526	CcSEcCtD
Flucytosine—Azotaemia—Mechlorethamine—lymphatic system cancer	0.0369	0.0397	CcSEcCtD
Flucytosine—DNMT1—Vinblastine—Vincristine—lymphatic system cancer	0.0324	1	CbGdCrCtD
Flucytosine—DNMT1—Negative epigenetic regulation of rRNA expression—RRP8—lymphatic system cancer	0.0189	0.491	CbGpPWpGaD
Flucytosine—DNMT1—Epigenetic regulation of gene expression—RRP8—lymphatic system cancer	0.0168	0.436	CbGpPWpGaD
Flucytosine—Azotaemia—Carmustine—lymphatic system cancer	0.0153	0.0165	CcSEcCtD
Flucytosine—Azotaemia—Vincristine—lymphatic system cancer	0.0146	0.0157	CcSEcCtD
Flucytosine—Hearing impaired—Fludarabine—lymphatic system cancer	0.0134	0.0144	CcSEcCtD
Flucytosine—Hepatic function abnormal—Teniposide—lymphatic system cancer	0.012	0.013	CcSEcCtD
Flucytosine—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.0117	0.0126	CcSEcCtD
Flucytosine—Jaundice—Mechlorethamine—lymphatic system cancer	0.0107	0.0115	CcSEcCtD
Flucytosine—Deafness—Fludarabine—lymphatic system cancer	0.0103	0.0111	CcSEcCtD
Flucytosine—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.0103	0.0111	CcSEcCtD
Flucytosine—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.00993	0.0107	CcSEcCtD
Flucytosine—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.00988	0.0106	CcSEcCtD
Flucytosine—Gastrointestinal haemorrhage—Fludarabine—lymphatic system cancer	0.00925	0.00996	CcSEcCtD
Flucytosine—Pancytopenia—Teniposide—lymphatic system cancer	0.00864	0.0093	CcSEcCtD
Flucytosine—Toxic epidermal necrolysis—Fludarabine—lymphatic system cancer	0.00833	0.00897	CcSEcCtD
Flucytosine—Neuropathy peripheral—Teniposide—lymphatic system cancer	0.00795	0.00856	CcSEcCtD
Flucytosine—Vertigo—Mechlorethamine—lymphatic system cancer	0.00773	0.00832	CcSEcCtD
Flucytosine—Leukopenia—Mechlorethamine—lymphatic system cancer	0.0077	0.00828	CcSEcCtD
Flucytosine—Pancytopenia—Fludarabine—lymphatic system cancer	0.00759	0.00817	CcSEcCtD
Flucytosine—Haemoglobin—Teniposide—lymphatic system cancer	0.00732	0.00788	CcSEcCtD
Flucytosine—Haemorrhage—Teniposide—lymphatic system cancer	0.00728	0.00784	CcSEcCtD
Flucytosine—Azotaemia—Methotrexate—lymphatic system cancer	0.00709	0.00763	CcSEcCtD
Flucytosine—Renal failure—Fludarabine—lymphatic system cancer	0.00701	0.00754	CcSEcCtD
Flucytosine—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.00699	0.00752	CcSEcCtD
Flucytosine—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00687	0.0074	CcSEcCtD
Flucytosine—Anorexia—Mechlorethamine—lymphatic system cancer	0.00669	0.0072	CcSEcCtD
Flucytosine—Haemoglobin—Fludarabine—lymphatic system cancer	0.00643	0.00692	CcSEcCtD
Flucytosine—Haemorrhage—Fludarabine—lymphatic system cancer	0.0064	0.00689	CcSEcCtD
Flucytosine—Deafness—Vincristine—lymphatic system cancer	0.00632	0.0068	CcSEcCtD
Flucytosine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.0061	0.00657	CcSEcCtD
Flucytosine—Gastrointestinal haemorrhage—Carmustine—lymphatic system cancer	0.00592	0.00637	CcSEcCtD
Flucytosine—Anaemia—Teniposide—lymphatic system cancer	0.00586	0.00631	CcSEcCtD
Flucytosine—Leukopenia—Teniposide—lymphatic system cancer	0.00568	0.00611	CcSEcCtD
Flucytosine—Pancytopenia—Bleomycin—lymphatic system cancer	0.00557	0.00599	CcSEcCtD
Flucytosine—Ataxia—Carmustine—lymphatic system cancer	0.00557	0.00599	CcSEcCtD
Flucytosine—Gastrointestinal haemorrhage—Mitoxantrone—lymphatic system cancer	0.00551	0.00592	CcSEcCtD
Flucytosine—Chest pain—Teniposide—lymphatic system cancer	0.0054	0.00581	CcSEcCtD
Flucytosine—Hypokalaemia—Carmustine—lymphatic system cancer	0.00539	0.0058	CcSEcCtD
Flucytosine—Cardiac arrest—Vincristine—lymphatic system cancer	0.00538	0.00578	CcSEcCtD
Flucytosine—Ataxia—Vincristine—lymphatic system cancer	0.00532	0.00572	CcSEcCtD
Flucytosine—Confusional state—Teniposide—lymphatic system cancer	0.00522	0.00561	CcSEcCtD
Flucytosine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00517	0.00557	CcSEcCtD
Flucytosine—Anaemia—Fludarabine—lymphatic system cancer	0.00515	0.00554	CcSEcCtD
Flucytosine—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00507	0.00545	CcSEcCtD
Flucytosine—Hypokalaemia—Mitoxantrone—lymphatic system cancer	0.00501	0.00539	CcSEcCtD
Flucytosine—Leukopenia—Fludarabine—lymphatic system cancer	0.00499	0.00537	CcSEcCtD
Flucytosine—Pruritus—Mechlorethamine—lymphatic system cancer	0.00497	0.00534	CcSEcCtD
Flucytosine—Anorexia—Teniposide—lymphatic system cancer	0.00493	0.00531	CcSEcCtD
Flucytosine—Pancytopenia—Carmustine—lymphatic system cancer	0.00486	0.00523	CcSEcCtD
Flucytosine—Convulsion—Fludarabine—lymphatic system cancer	0.00483	0.0052	CcSEcCtD
Flucytosine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0048	0.00517	CcSEcCtD
Flucytosine—Haemoglobin—Bleomycin—lymphatic system cancer	0.00472	0.00508	CcSEcCtD
Flucytosine—Haemorrhage—Bleomycin—lymphatic system cancer	0.00469	0.00505	CcSEcCtD
Flucytosine—Pancytopenia—Vincristine—lymphatic system cancer	0.00464	0.00499	CcSEcCtD
Flucytosine—Dyspnoea—Teniposide—lymphatic system cancer	0.00461	0.00496	CcSEcCtD
Flucytosine—Confusional state—Fludarabine—lymphatic system cancer	0.00459	0.00493	CcSEcCtD
Flucytosine—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00452	0.00486	CcSEcCtD
Flucytosine—Decreased appetite—Teniposide—lymphatic system cancer	0.0045	0.00484	CcSEcCtD
Flucytosine—Renal failure—Carmustine—lymphatic system cancer	0.00449	0.00483	CcSEcCtD
Flucytosine—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00447	0.00481	CcSEcCtD
Flucytosine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00446	0.0048	CcSEcCtD
Flucytosine—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00446	0.0048	CcSEcCtD
Flucytosine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00445	0.00479	CcSEcCtD
Flucytosine—Rash—Mechlorethamine—lymphatic system cancer	0.00443	0.00476	CcSEcCtD
Flucytosine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00442	0.00476	CcSEcCtD
Flucytosine—Anorexia—Fludarabine—lymphatic system cancer	0.00433	0.00467	CcSEcCtD
Flucytosine—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00427	0.0046	CcSEcCtD
Flucytosine—Feeling abnormal—Teniposide—lymphatic system cancer	0.00426	0.00459	CcSEcCtD
Flucytosine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00423	0.00455	CcSEcCtD
Flucytosine—Renal failure—Mitoxantrone—lymphatic system cancer	0.00417	0.00449	CcSEcCtD
Flucytosine—Nausea—Mechlorethamine—lymphatic system cancer	0.00417	0.00449	CcSEcCtD
Flucytosine—Jaundice—Mitoxantrone—lymphatic system cancer	0.00414	0.00445	CcSEcCtD
Flucytosine—Haemoglobin—Carmustine—lymphatic system cancer	0.00412	0.00443	CcSEcCtD
Flucytosine—Urticaria—Teniposide—lymphatic system cancer	0.00411	0.00442	CcSEcCtD
Flucytosine—Haemorrhage—Carmustine—lymphatic system cancer	0.0041	0.00441	CcSEcCtD
Flucytosine—Abdominal pain—Teniposide—lymphatic system cancer	0.00409	0.0044	CcSEcCtD
Flucytosine—Body temperature increased—Teniposide—lymphatic system cancer	0.00409	0.0044	CcSEcCtD
Flucytosine—Paraesthesia—Fludarabine—lymphatic system cancer	0.00408	0.00439	CcSEcCtD
Flucytosine—Hallucination—Carmustine—lymphatic system cancer	0.00408	0.00439	CcSEcCtD
Flucytosine—Dyspnoea—Fludarabine—lymphatic system cancer	0.00405	0.00436	CcSEcCtD
Flucytosine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00396	0.00426	CcSEcCtD
Flucytosine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00395	0.00425	CcSEcCtD
Flucytosine—Fatigue—Fludarabine—lymphatic system cancer	0.00392	0.00422	CcSEcCtD
Flucytosine—Hallucination—Vincristine—lymphatic system cancer	0.00389	0.00419	CcSEcCtD
Flucytosine—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00383	0.00412	CcSEcCtD
Flucytosine—Hypersensitivity—Teniposide—lymphatic system cancer	0.00381	0.0041	CcSEcCtD
Flucytosine—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00381	0.0041	CcSEcCtD
Flucytosine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00381	0.0041	CcSEcCtD
Flucytosine—Anaemia—Bleomycin—lymphatic system cancer	0.00378	0.00406	CcSEcCtD
Flucytosine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00375	0.00403	CcSEcCtD
Flucytosine—Asthenia—Teniposide—lymphatic system cancer	0.00371	0.004	CcSEcCtD
Flucytosine—Pruritus—Teniposide—lymphatic system cancer	0.00366	0.00394	CcSEcCtD
Flucytosine—Leukopenia—Bleomycin—lymphatic system cancer	0.00366	0.00394	CcSEcCtD
Flucytosine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00359	0.00387	CcSEcCtD
Flucytosine—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00355	0.00382	CcSEcCtD
Flucytosine—Diarrhoea—Teniposide—lymphatic system cancer	0.00354	0.00381	CcSEcCtD
Flucytosine—Chest pain—Bleomycin—lymphatic system cancer	0.00348	0.00374	CcSEcCtD
Flucytosine—Confusional state—Bleomycin—lymphatic system cancer	0.00336	0.00362	CcSEcCtD
Flucytosine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00335	0.00361	CcSEcCtD
Flucytosine—Anaemia—Carmustine—lymphatic system cancer	0.0033	0.00355	CcSEcCtD
Flucytosine—Vomiting—Teniposide—lymphatic system cancer	0.00329	0.00354	CcSEcCtD
Flucytosine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00326	0.00351	CcSEcCtD
Flucytosine—Asthenia—Fludarabine—lymphatic system cancer	0.00326	0.00351	CcSEcCtD
Flucytosine—Rash—Teniposide—lymphatic system cancer	0.00326	0.00351	CcSEcCtD
Flucytosine—Dermatitis—Teniposide—lymphatic system cancer	0.00326	0.00351	CcSEcCtD
Flucytosine—Headache—Teniposide—lymphatic system cancer	0.00324	0.00349	CcSEcCtD
Flucytosine—Pruritus—Fludarabine—lymphatic system cancer	0.00322	0.00346	CcSEcCtD
Flucytosine—Leukopenia—Carmustine—lymphatic system cancer	0.00319	0.00344	CcSEcCtD
Flucytosine—Anorexia—Bleomycin—lymphatic system cancer	0.00318	0.00342	CcSEcCtD
Flucytosine—Anaemia—Vincristine—lymphatic system cancer	0.00315	0.00339	CcSEcCtD
Flucytosine—Photosensitivity—Methotrexate—lymphatic system cancer	0.00312	0.00336	CcSEcCtD
Flucytosine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00311	0.00335	CcSEcCtD
Flucytosine—Convulsion—Carmustine—lymphatic system cancer	0.00309	0.00333	CcSEcCtD
Flucytosine—Nausea—Teniposide—lymphatic system cancer	0.00307	0.00331	CcSEcCtD
Flucytosine—Anaemia—Mitoxantrone—lymphatic system cancer	0.00306	0.0033	CcSEcCtD
Flucytosine—Vertigo—Vincristine—lymphatic system cancer	0.00306	0.00329	CcSEcCtD
Flucytosine—Leukopenia—Vincristine—lymphatic system cancer	0.00305	0.00328	CcSEcCtD
Flucytosine—Chest pain—Carmustine—lymphatic system cancer	0.00304	0.00327	CcSEcCtD
Flucytosine—Paraesthesia—Bleomycin—lymphatic system cancer	0.00299	0.00322	CcSEcCtD
Flucytosine—Dyspnoea—Bleomycin—lymphatic system cancer	0.00297	0.0032	CcSEcCtD
Flucytosine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00297	0.00319	CcSEcCtD
Flucytosine—Convulsion—Vincristine—lymphatic system cancer	0.00295	0.00317	CcSEcCtD
Flucytosine—Confusional state—Carmustine—lymphatic system cancer	0.00293	0.00316	CcSEcCtD
Flucytosine—Decreased appetite—Bleomycin—lymphatic system cancer	0.0029	0.00312	CcSEcCtD
Flucytosine—Vomiting—Fludarabine—lymphatic system cancer	0.00289	0.00311	CcSEcCtD
Flucytosine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00287	0.00309	CcSEcCtD
Flucytosine—Rash—Fludarabine—lymphatic system cancer	0.00287	0.00309	CcSEcCtD
Flucytosine—Dermatitis—Fludarabine—lymphatic system cancer	0.00286	0.00308	CcSEcCtD
Flucytosine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00285	0.00307	CcSEcCtD
Flucytosine—Headache—Fludarabine—lymphatic system cancer	0.00285	0.00307	CcSEcCtD
Flucytosine—Chest pain—Mitoxantrone—lymphatic system cancer	0.00282	0.00304	CcSEcCtD
Flucytosine—DNMT1—Gene Expression—RRP8—lymphatic system cancer	0.0028	0.0728	CbGpPWpGaD
Flucytosine—Anorexia—Carmustine—lymphatic system cancer	0.00277	0.00299	CcSEcCtD
Flucytosine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00275	0.00296	CcSEcCtD
Flucytosine—Confusional state—Mitoxantrone—lymphatic system cancer	0.00273	0.00294	CcSEcCtD
Flucytosine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00272	0.00293	CcSEcCtD
Flucytosine—Nausea—Fludarabine—lymphatic system cancer	0.0027	0.00291	CcSEcCtD
Flucytosine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00265	0.00285	CcSEcCtD
Flucytosine—Urticaria—Bleomycin—lymphatic system cancer	0.00265	0.00285	CcSEcCtD
Flucytosine—Anorexia—Vincristine—lymphatic system cancer	0.00265	0.00285	CcSEcCtD
Flucytosine—Body temperature increased—Bleomycin—lymphatic system cancer	0.00264	0.00284	CcSEcCtD
Flucytosine—Paraesthesia—Carmustine—lymphatic system cancer	0.00261	0.00281	CcSEcCtD
Flucytosine—Dyspnoea—Carmustine—lymphatic system cancer	0.00259	0.00279	CcSEcCtD
Flucytosine—Anorexia—Mitoxantrone—lymphatic system cancer	0.00258	0.00278	CcSEcCtD
Flucytosine—Ataxia—Methotrexate—lymphatic system cancer	0.00258	0.00278	CcSEcCtD
Flucytosine—Decreased appetite—Carmustine—lymphatic system cancer	0.00253	0.00272	CcSEcCtD
Flucytosine—Paraesthesia—Vincristine—lymphatic system cancer	0.00249	0.00268	CcSEcCtD
Flucytosine—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00247	0.00266	CcSEcCtD
Flucytosine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00246	0.00264	CcSEcCtD
Flucytosine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00243	0.00261	CcSEcCtD
Flucytosine—Decreased appetite—Vincristine—lymphatic system cancer	0.00242	0.0026	CcSEcCtD
Flucytosine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00241	0.0026	CcSEcCtD
Flucytosine—Feeling abnormal—Carmustine—lymphatic system cancer	0.0024	0.00258	CcSEcCtD
Flucytosine—Fatigue—Vincristine—lymphatic system cancer	0.0024	0.00258	CcSEcCtD
Flucytosine—Asthenia—Bleomycin—lymphatic system cancer	0.00239	0.00257	CcSEcCtD
Flucytosine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00238	0.00256	CcSEcCtD
Flucytosine—Pruritus—Bleomycin—lymphatic system cancer	0.00236	0.00254	CcSEcCtD
Flucytosine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00235	0.00253	CcSEcCtD
Flucytosine—Eosinophilia—Methotrexate—lymphatic system cancer	0.00235	0.00253	CcSEcCtD
Flucytosine—Fatigue—Mitoxantrone—lymphatic system cancer	0.00233	0.00251	CcSEcCtD
Flucytosine—Body temperature increased—Carmustine—lymphatic system cancer	0.0023	0.00248	CcSEcCtD
Flucytosine—Abdominal pain—Carmustine—lymphatic system cancer	0.0023	0.00248	CcSEcCtD
Flucytosine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00227	0.00245	CcSEcCtD
Flucytosine—Pancytopenia—Methotrexate—lymphatic system cancer	0.00225	0.00242	CcSEcCtD
Flucytosine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00223	0.0024	CcSEcCtD
Flucytosine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00221	0.00238	CcSEcCtD
Flucytosine—Abdominal pain—Vincristine—lymphatic system cancer	0.0022	0.00236	CcSEcCtD
Flucytosine—Body temperature increased—Vincristine—lymphatic system cancer	0.0022	0.00236	CcSEcCtD
Flucytosine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00216	0.00233	CcSEcCtD
Flucytosine—Urticaria—Mitoxantrone—lymphatic system cancer	0.00215	0.00231	CcSEcCtD
Flucytosine—Hypersensitivity—Carmustine—lymphatic system cancer	0.00214	0.00231	CcSEcCtD
Flucytosine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00214	0.0023	CcSEcCtD
Flucytosine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00214	0.0023	CcSEcCtD
Flucytosine—Vomiting—Bleomycin—lymphatic system cancer	0.00212	0.00228	CcSEcCtD
Flucytosine—Rash—Bleomycin—lymphatic system cancer	0.0021	0.00226	CcSEcCtD
Flucytosine—Dermatitis—Bleomycin—lymphatic system cancer	0.0021	0.00226	CcSEcCtD
Flucytosine—Asthenia—Carmustine—lymphatic system cancer	0.00209	0.00225	CcSEcCtD
Flucytosine—Renal failure—Methotrexate—lymphatic system cancer	0.00208	0.00224	CcSEcCtD
Flucytosine—Hypersensitivity—Vincristine—lymphatic system cancer	0.00205	0.0022	CcSEcCtD
Flucytosine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00199	0.00215	CcSEcCtD
Flucytosine—Asthenia—Vincristine—lymphatic system cancer	0.00199	0.00215	CcSEcCtD
Flucytosine—Diarrhoea—Carmustine—lymphatic system cancer	0.00199	0.00214	CcSEcCtD
Flucytosine—Nausea—Bleomycin—lymphatic system cancer	0.00198	0.00213	CcSEcCtD
Flucytosine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00197	0.00212	CcSEcCtD
Flucytosine—Asthenia—Mitoxantrone—lymphatic system cancer	0.00194	0.00209	CcSEcCtD
Flucytosine—Haemoglobin—Methotrexate—lymphatic system cancer	0.00191	0.00205	CcSEcCtD
Flucytosine—Diarrhoea—Vincristine—lymphatic system cancer	0.0019	0.00205	CcSEcCtD
Flucytosine—Hepatitis—Methotrexate—lymphatic system cancer	0.0019	0.00204	CcSEcCtD
Flucytosine—Haemorrhage—Methotrexate—lymphatic system cancer	0.0019	0.00204	CcSEcCtD
Flucytosine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00185	0.00199	CcSEcCtD
Flucytosine—Vomiting—Carmustine—lymphatic system cancer	0.00185	0.00199	CcSEcCtD
Flucytosine—Rash—Carmustine—lymphatic system cancer	0.00184	0.00197	CcSEcCtD
Flucytosine—Dermatitis—Carmustine—lymphatic system cancer	0.00183	0.00197	CcSEcCtD
Flucytosine—Headache—Carmustine—lymphatic system cancer	0.00182	0.00196	CcSEcCtD
Flucytosine—Vomiting—Vincristine—lymphatic system cancer	0.00177	0.0019	CcSEcCtD
Flucytosine—Rash—Vincristine—lymphatic system cancer	0.00175	0.00189	CcSEcCtD
Flucytosine—Dermatitis—Vincristine—lymphatic system cancer	0.00175	0.00188	CcSEcCtD
Flucytosine—Headache—Vincristine—lymphatic system cancer	0.00174	0.00187	CcSEcCtD
Flucytosine—Nausea—Carmustine—lymphatic system cancer	0.00173	0.00186	CcSEcCtD
Flucytosine—Vomiting—Mitoxantrone—lymphatic system cancer	0.00172	0.00185	CcSEcCtD
Flucytosine—Rash—Mitoxantrone—lymphatic system cancer	0.00171	0.00184	CcSEcCtD
Flucytosine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.0017	0.00183	CcSEcCtD
Flucytosine—Headache—Mitoxantrone—lymphatic system cancer	0.0017	0.00182	CcSEcCtD
Flucytosine—Nausea—Vincristine—lymphatic system cancer	0.00165	0.00178	CcSEcCtD
Flucytosine—Nausea—Mitoxantrone—lymphatic system cancer	0.00161	0.00173	CcSEcCtD
Flucytosine—Anaemia—Methotrexate—lymphatic system cancer	0.00153	0.00164	CcSEcCtD
Flucytosine—Vertigo—Methotrexate—lymphatic system cancer	0.00148	0.0016	CcSEcCtD
Flucytosine—Leukopenia—Methotrexate—lymphatic system cancer	0.00148	0.00159	CcSEcCtD
Flucytosine—Convulsion—Methotrexate—lymphatic system cancer	0.00143	0.00154	CcSEcCtD
Flucytosine—Chest pain—Methotrexate—lymphatic system cancer	0.00141	0.00151	CcSEcCtD
Flucytosine—Confusional state—Methotrexate—lymphatic system cancer	0.00136	0.00146	CcSEcCtD
Flucytosine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00132	0.00142	CcSEcCtD
Flucytosine—Anorexia—Methotrexate—lymphatic system cancer	0.00129	0.00138	CcSEcCtD
Flucytosine—Paraesthesia—Methotrexate—lymphatic system cancer	0.00121	0.0013	CcSEcCtD
Flucytosine—Dyspnoea—Methotrexate—lymphatic system cancer	0.0012	0.00129	CcSEcCtD
Flucytosine—Decreased appetite—Methotrexate—lymphatic system cancer	0.00117	0.00126	CcSEcCtD
Flucytosine—Fatigue—Methotrexate—lymphatic system cancer	0.00116	0.00125	CcSEcCtD
Flucytosine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00111	0.0012	CcSEcCtD
Flucytosine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.0011	0.00119	CcSEcCtD
Flucytosine—Urticaria—Methotrexate—lymphatic system cancer	0.00107	0.00115	CcSEcCtD
Flucytosine—Abdominal pain—Methotrexate—lymphatic system cancer	0.00107	0.00115	CcSEcCtD
Flucytosine—Body temperature increased—Methotrexate—lymphatic system cancer	0.00107	0.00115	CcSEcCtD
Flucytosine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000993	0.00107	CcSEcCtD
Flucytosine—Asthenia—Methotrexate—lymphatic system cancer	0.000967	0.00104	CcSEcCtD
Flucytosine—Pruritus—Methotrexate—lymphatic system cancer	0.000954	0.00103	CcSEcCtD
Flucytosine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000922	0.000993	CcSEcCtD
Flucytosine—Vomiting—Methotrexate—lymphatic system cancer	0.000857	0.000922	CcSEcCtD
Flucytosine—Rash—Methotrexate—lymphatic system cancer	0.00085	0.000915	CcSEcCtD
Flucytosine—Dermatitis—Methotrexate—lymphatic system cancer	0.000849	0.000914	CcSEcCtD
Flucytosine—Headache—Methotrexate—lymphatic system cancer	0.000845	0.000909	CcSEcCtD
Flucytosine—Nausea—Methotrexate—lymphatic system cancer	0.000801	0.000862	CcSEcCtD
